Gepostet in 2019.02.21. 23:35
NEW YORK, Feb. 21, 2019 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS). Such investors are advised to contact Robert S. Willoughby at firstname.lastname@example.org or 888-476-6529, ext. 9980. The investigation concerns whether CVS and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here to join a class action] On February 20, 2019, CVS announced the Company’s fourth quarter and full year financial and operating results and provided 2019 full year guidance. CVS advised investors that adjusted earnings in 2019 would be $6.68 to ...
Gepostet in der Kategorie Wirtschaft (Anzahl der ansichten:) 2